Why the study?
Does intravenous infusion of Sar1-Thr8-angiotensin II reduce arterial pressure in the acute and chronic phases of two-kidney hypertension in dogs?
Does intravenous infusion of Sar1-Thr8-angiotensin II reduce arterial pressure in the acute and chronic phases of two-kidney hypertension in dogs?
Answers are grounded in this paper and cite their sources.
The renin-angiotensin system does not appear to be directly involved in the chronic phase of two-kidney hypertension in this dog model.
We describe a new method of producing two-kidney hypertension in dogs by a two-step procedure with complete occlusion of a renal artery 2 weeks after it was partially constricted. 2. Control mean arterial pressure (96 +/- 3 mmHg) of nine conscious, trained dogs rose to 107 +/- 3 mmHg 2 weeks after partial constriction of a renal artery, and it stabilized at a sustained hypertensive plateau (124 +/- 7 mmHg) 3 weeks after complete occlusion. 3. Intravenous infusion of an angiotensin II antagonist (Sar1-Thr8-angiotensin II) caused arterial pressure to fall during the acute but not the chronic phase of renal hypertension. In this latter phase plasma renin activity had returned to control values. 4. We conclude that the renin-angiotensin system appears not to be directly involved in the chronic phase of two-kidney hypertension in the dog.
No takes yet. Share an insight, caveat, or question.
Masaki et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: